Actual Medicinal Product (AMP) Zestoretic 20 tablets (DE Pharmaceuticals)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Light sensitive medicine. Store in light resistant container. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Zestoretic 20 tablets (Atnahs Pharma UK Ltd) and lisinopril/hydrochlorothiazide 20mg/12.5mg tablets (TEVA UK Limited).
- Generic
- Lisinopril + Hydrochlorothiazide
- Formulation
- Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets
-
Lisinopril + Hydrochlorothiazide
-
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets
-
Zestoretic 20 tablets (DE Pharmaceuticals)
-
-